Role of endothelial cell stress in the pathogenesis of chronic heart failure

Frontiers in Bioscience

Volumn 14, Issue 6, 2009, Pages 2238-2247

  Anzalone, Rita ^a   La Rocca, Giampiero ^a   Di Stefano, Antonino ^b   Magno, Francesca ^a   Corrao, Simona ^a   Carbone, Marco ^a,b   Loria, Tiziana ^a   Lo Iacono, Melania ^a   Eleuteri, Ermanno ^b   Colombo, Marilena ^b   Cappello, Francesco ^a   Farina, Felicia ^a   Zummo, Giovanni ^a   Giannuzzi, Pantaleo ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b IRCCS   (Italy)

Author keywords

3 chlorotyrosine; 3 nitrotyrosine; Endothelial cells; Enos; Hydrogen peroxide; Myeloperoxidase; Nitric oxide; Nitrosylaton; Oxidative stress; Review; Rns; Ros; Superoxide

Indexed keywords

PEROXIDASE; REACTIVE OXYGEN METABOLITE;

CHRONIC DISEASE; ENZYMOLOGY; HEART FAILURE; HUMAN; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

CHRONIC DISEASE; ENDOTHELIUM, VASCULAR; HEART FAILURE; HUMANS; OXIDATIVE STRESS; PEROXIDASE; REACTIVE OXYGEN SPECIES;

EID: 63849331361     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3376     Document Type: Article

References (93)

1. W. Risau, I. Flamme: Vasculogenesis. Ann Rev Cell Dev Biol 11, 73-91 (1995). (Pubitemid 26019602)
2. J. E. Ferguson III, R. W. Kelley, C. Patterson: Mechanisms of endothelial differentiation in embryonic vasculogenesis. Arterioscler Thromb Vasc Biol 25, 2246-2254 (2005). (Pubitemid 41552639)
3. A. Ratajska, E. Czarnowska, A. Kolodzinska, W. Kluzek, W. Lesniak: Vasulogenesis of the embryonic heart: origin of blood island-like structures. Anat Rec A Discov Mol Cell Evol Biol 288, 223-232 (2006).
4. A. Schmidt, K. Brixius, W. Bloch: Endothelial precursor cell migration during vasulogenesis. Circ Res 101, 125-136 (2007). (Pubitemid 47196580)
5. M. Hristov, C. Weber: Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 8, 498-508 (2004). (Pubitemid 44145482)
6. M. G. Achen, S. A. Stacker: The vascular endothelial growth factor family: proteins which guide the development of the vasculature. Int J Exp Pathol 79, 255-265 (1998). (Pubitemid 28481534)
7. D. B. Cines, E. S. Pollack, C. A. Buck, J. Loscalzo, G. A. Zimmerman, R. P. McEver, J. S. Pober, T. M. Wick, B. A. Konkle, B. S. Schwarts, E. S. Barnathan, K. R. McCrae, B. A. Hug, A. M. Schmidt, D. M. Stern: Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91, 3527-3561 (1998). (Pubitemid 28225719)
8. T. Mustonen, K. Alitalo: Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129, 895-898 (1995).
9. E.A. Jaffe, R.L. Nachman, C.G. Becker, C.R. Minick: Culture of human endothelial cells derived from umbilical veins: Identification by morphologic criteria. J Clin Invest 52, 2745-2756 (1973).
10. T. Maciag, G. A. Hoover, M. B. Stemerman, R. Weinstein: Serial propagation of human endothelial cells in vitro. J Cell Biol 91, 420-426 (1981). (Pubitemid 12215630)
11. V. Marin, G. Kaplanski, S. Gres, C. Farnarier, P. Bongrand: Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J Immunol Methods 254, 183-190 (2001). (Pubitemid 32530758)
12. A. J. Donato, I. Eskurza, A. E. Silver, A. S. Levy, G. L. Pierce, P. E. Gates, D. R. Seals: Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ Res 100, 1659-1666 (2007). (Pubitemid 46897269)
13. J. Jacobi, B. Kristal, J. Chezar, S. M. Shaul, S. Sela: Exogenous superoxide mediates pro-oxidative, proinflammatory, and procoagulatory changes in primary endothelial cell cultures. Free Radic Bol Med 39, 1238-1248 (2005). (Pubitemid 41407716)
14. W. C. Aird: Endothelium and allotransplantation. Transplantation; 82 (Suppl 1), S6-S8 (2006). (Pubitemid 44035977)
15. M. L. Balestrieri, C. Napoli: Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors. Eur J Cancer; 43, 1242-1250 (2007). (Pubitemid 46729702)
16. W. C. Aird: Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100, 158-173 (2007). (Pubitemid 46208717)
17. E. A. Jaffe, L. W. Hoyer, R. L. Nachman: Synthesis of von Willebrand factor by cultured human endothelial cells. PNAS USA 71, 1906-1909 (1974).
18. S. Kumar, D. C. West, A. Ager: Heterogeneity in endothelial cells from large vessels and microvessels. Differentiation 36, 57-70 (1978).
19. R. R. Turner, J. H. Beckstead, R. A. Warnke, G. S. Woods: Endothelial cell phenotypic diversity. In situ demonstration of immunologic and enzymatic heterogeneity that correlates with specific morphologic subtypes. Am J Clin Pathol 87, 569-575 (1987). (Pubitemid 17076593)
20. R. E. Unger, V. Krump-Konvalinkova, K. Peters, C. J. Kirkpatrick: In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvascular Res 64, 384-397 (2002). (Pubitemid 35370740)
21. S. Baldus, J. P. Eiserich, A. Mani, L. Castro, M. Figueroa, P. Chumley, W. Ma, A. Tousson, C. R. White, D. C. Bullard, M.-L. Brennan, A. J. Lusis, K. P. Moore, B. A. Freeman: Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 108, 1759-1770 (2001). (Pubitemid 34015121)
22. M. Simionescu, A. Gafencu, F. Antohe: Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey. Microsc Res Tech 57, 269-288 (2002). (Pubitemid 34579213)
23. C. Tiruppathi, T. Naqvi, Y. Wu, S. M. Vogel, R. D. Minshall, A. B. Malik: Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells. PNAS USA 101, 7699-7704 (2004). (Pubitemid 38658092)
24. T. Michel, O. Feron: Nitric oxide sythases: Which, where how and why? J Clin Invest 100, 2146-2152 (1997).
25. P. Kubes, M. Suzuki, D. N. Granger: Nitric oxide: An endogenous modulator of leukocyte adhesion. PNAS USA 88: 4651-4655 (1991). (Pubitemid 21914599)
26. R. De Caterina, P. Libby, H. B. Peng, V. J. Thannickal, T. B. Rajavashisth, M. A. Gimbrone Jr, W. S. Shin, J. K. Liao: Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96, 60-68 (1995).
27. D. S. Marks, J. A. Vita, J. D. Folts, J. F. Keany, G. N. Welch, J. Loscalzo: Inhibition of neointimal proliferation in rabbits following vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest 96, 2630-2638 (1995).
28. U. C. Garg, A. Hassid: Nitric oxide (NO) and 8-bromocyclic GMP inhibit mitogenesis and proliferation of cultured rat vascular smoth muscle cells. J Clin Invest 83, 1774-1777 (1989). (Pubitemid 19124139)
29. K. Fukuo, T. Inoue, S. Morimoto, T. Nakahasi, O. Yasuda, S. Kitanno, A. Sasanda, T. Ogihara: Nitric oxide mediates cytoxicity and basic fibroblasts growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques. J Clin Invest 95, 669-676 (1995).
30. C. F. Mueller, K. Laude, J. S. McNally, D. G. Harrison: ATVB in focus: redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol 25, 274-278 (2005). (Pubitemid 40189145)
31. I. Fridovich: Superoxide anion radical (O2-.), superoxide dismutases, and related matters. J Biol Chem 272, 18515-18517 (1997). (Pubitemid 27318184)
32. W. Droge: Free radicals in the physiological control of cell function. Physiol Rev 82, 47-95 (2002). (Pubitemid 34654215)
33. J. M. Hare, J. S. Stamler: NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest 115, 509-517 (2005). (Pubitemid 40322220)
34. A. Linke, F. Recchia, X. Zhang, T. H. Hintze: Acute and Chronic Endothelial Dysfunction: Implications for the Development of Heart Failure. Heart Failure Rev 8, 87-97 (2003). (Pubitemid 36342292)
35. J. Bauersachs, A. Bouloumie, D. Fraccarollo, K. Hu, R. Busse, G. Ertl: Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: Role of enhanced vascular superoxide production. Circulation 100, 292-298 (1999). (Pubitemid 29340137)
36. T. P. Cappola, D. A. Kass, G. S. Nelson, R. D. Berger, G. O. Rosas, Z. A. Kobeissi, E. Marban, J. M. Hare: Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 104, 2407-2411 (2001). (Pubitemid 33108372)
37. D. Yucel, S. Aydogdu, S. Cehreli, G. Saydam, H. Canatan, M. Senes, T. B. Cigdem, S. Nebioglu: Increased oxidative stress in dilated cardiomyopathic heart failure. Clin Chem 44, 148-154 (1998). (Pubitemid 28042480)
38. M. Schäfer, C. Schäfer, N. Ewald, H. M. Piper, T. Noll: Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia. Circ Res 92, 1010-1015 (2003). (Pubitemid 36588500)
39. S. Baldus, K. Müllerleile, P. Chumley, D. Steven, V. Rudolph, G. K. Lund, H. J. Staude, A. Stork, R. Köster, J. Kähler, C. Weiss, T. Munzel, T. Meinertz, B. A. Freeman, T. Heitzer: Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy. Free Rad Biol Med 41, 1282-1288 (2006). (Pubitemid 44466324)
40. M. Seddon, Y. H. Looi, A. M. Shah: Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93, 903-907 (2007). (Pubitemid 47122034)
41. C. E. Berry, J. M. Hare: Xanthine oxidoreductase in the cardiovascular system: molecular mechanisms and pathophysiologic implications. J. Physiol. 555, 589-606 (2004). (Pubitemid 38404582)
42. W. F. Saavedra, N. Paolocci, M. E. St. John, M. W. Skaf, G. C. Stewart, J.-S. Xie, R. W. Harrison, J. Zeichner, D. Mudrick, E. Marbán, D. A. Kass, J. M. Hare: Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ. Res.90, 297-304 (2002). (Pubitemid 34633931)
43. J. A. Ruiz-Gines, S. Lopez-Ongil, M. Gonzalez-Rubio, L. Gonzalez-Santiago, M. Rodriguez-Puyol, D. Rodriguez-Puyol: Reactive oxygen species induce proliferation of bovine aortic endothelial cells. J Cardiovasc Pharm 35, 109-113 (2000). (Pubitemid 30032901)
44. 2 in rat heart endothelial cells. Free Radic Biol Med 25, 891-897 (1998). (Pubitemid 28538554)
45. M. Eyries, T. Collins, L. M. Khachigian: Modulation of growth factor gene expression in vascular cells by oxidative stress. Endothelium 11, 133-139 (2004). (Pubitemid 39207186)
46. A. Ramachandran, D. Moellering, Y. M. Go, S. Shiva, A. L. Levonen, H. Jo, R. P. Patel, S. Parthasarathy, V. M. Darley-Usmar: Activation of c-Jun N-terminal kinase and apoptosis in endothelial cells mediated by endogenous generation of hydrogen peroxide. Biol Chem 383, 693-701 (2002). (Pubitemid 34506306)
47. S. J. Lin, S. K. Shyue, P. L. Liu, Y. H. Chen, H. H. Ku, J. W. Chen, K. B. Tam, Y. L. Chen: Adenovirus-mediated overexpression of catalase attenuates oxLDL-induced apoptosis in human aortic endothelial cells via AP-1 and C-Jun N-terminal kinase/extracellular signal-regulated kinase mitogen-activated protein kinase pathways. J Mol Cell Cardiol 36, 129-139 (2004).
48. J. Y. Liou, S. Lee, D. Ghelani, N. Matijevic-Aleksic, K. K. Wu: Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation. Arterioscler Thromb Vasc Biol 26, 1481-1487 (2006). (Pubitemid 44288972)
49. D. A. Ingram, T. R. Krier, L. E. Mead, C. McGuire, D. N. Prater, J. Bhavsar, M. R. Saadatzadeh, K. Bijangi-Vishehsaraei, F. Li, M. C. Yoder, L. S. Haneline: Clonogenic endothelial progenitor cells are sensitive to oxidative stress. Stem Cells 25, 297-304 (2007). (Pubitemid 46232783)
50. nd revision, (2008).
51. U. Rauen, T. Li, H. de Groot: Inhibitory and enhancing effects of NO on H(2)O(2) toxicity: dependence on the concentrations of NO and H(2)O(2). Free Radic Res 41, 402-412 (2007). (Pubitemid 46470938)
52. S. R. Thomas, K. Chen, J. F. Keaney Jr: Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem 277, 6017-6024 (2002). (Pubitemid 34968385)
53. S. Saitoh, C. Zhang, J. D. Tune, B. Potter, T. Kiyooka, P. A. Rogers, J. D. Knudson, G. M. Dick, A. Swafford, W. M. Chilian: Hydrogen peroxide: A feed-forward dilator that couples myocardial metabolism to coronary blood flow. Arterioscler Thromb Vasc Biol 26, 2614-2621 (2006).
54. K. T. Kang, J. C. Sllivan J. M. Sasser, J. D. Imig, J. S. Pollock: Novel nitric oxide synthase-dependent mechanism of vasorelaxation in small arteries from hypertensive rats. Hypertension 49, 893-901 (2007). (Pubitemid 351664232)
55. Y. Taniyama, K. K. Griendling: Reactive Oxygen Species in the Vasculature: Molecular and Cellular Mechanisms. Hypertension 42, 1075-1081 (2003). (Pubitemid 37549058)
56. K. Chalupsky, H. Cai: Endothelial dihydrofolate reductase: Critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. PNAS USA 102, 9056-9061. (2005). (Pubitemid 40881077)
57. U. Landmesser, S. Dikalov, S. R. Price, L. McCann, T. Fukai, S. M. Holland, W. E. Mitch, D. G. Harrison: Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111, 1201-1209 (2003). (Pubitemid 36519937)
58. A. L. Moens, D. A. Kass: Tetrahydrobiopterin and cardiovascular disease. Arterioscler Thromb. Vasc. Biol 26, 2439-2444 (2006). (Pubitemid 44607463)
59. J. M. Kinkade Jr, S. O. Pember, K. C. Barnes, R. Shapira, J. K. Spitznagel, L. E. Martin: Differential distribution of distinct forms of myeloperoxidase in different azurophilic granule subpopolations from human neutrophils. Biochem Biophys Res Commun 114, 296-303 (1983). (Pubitemid 13079123)
60. P. S. Green, A. J. Mendez, J. S. Jacob, J. R. Crowley, W. Growdon, B. T. Hyman: Neuronal expression of myeloperoxidase is increased in Alzheimer's disease. J Neurochem 90, 724-733 (2004). (Pubitemid 38989404)
61. A. P. Kumar, F. J. Piedrafita, W. F. Reynolds: Peroxisome proliferator-activated receptor γ ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the 463 GA promoter polymorphism. J Biol Chem 279, 8300-8315 (2004). (Pubitemid 38294722)
62. S. Sugiyama, Y. Okada, G. K. Sukhova, R. Virmani, J. W. Heinecke, P. Libby: Macrophage myeloperoxidase regulation by granulocyte macrophage colonysimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158, 879-891 (2001). (Pubitemid 32221781)
63. B. Schmekel, Y. Hornblad, M. Linden, C. Sundstrom, P. Venge: Myeloperoxidase in human lung lavage. H. Internalization of myeloperoxidase by alveolar macrophages. Inflammation 14, 455-461 (1990). (Pubitemid 20206258)
64. V. L. Shepherd, J. R. Hoidal: Clearance of neutrophil-derived myeloperoxidase by the macrophage mannose receptor. Am J Respir Cell Mol Biol 2, 335-340 (1990).
65. B. M. Babior: Oxygen-dependent microbial killing by phagocytes. N. Engl J Med 298, 659-668 (1978).
66. S. J. Klebanoff: Iodination of bacteria: A bactericidal mechanism. J Exp Med 126, 1063-1078 (1967).
67. S.J. Klebanoff: Myeloperoxidase: friend and foe. J Leukocyte Biol 77, 598-625 (2005). (Pubitemid 40628741)
68. J. P. Gaut, G. C. Yeh, H. D. Tran, J. Byun, J. P. Henderson, G. M. Richter, M. L. Brennan, A. J. Lusis, A. Belaaouaj, R. S. Hotchkiss, J. W. Heinecke: Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. PNAS USA 98, 11961-11966 (2001). (Pubitemid 32959809)
69. E. A. Podrez, H. M. Abu-Soud, S. L. Hazen. Myeloperoxidase-generated oxidants and atherosclerosis. Free Rad Biol Med 28, 1717-1725 (2000). (Pubitemid 30628658)
70. E. W. Odell, A. W. Segal: The bactericidal effects of the respiratory burst and the myeloperoxidase system isolated in neutrophil cytoplasts. Biochim Biophys Acta 971, 266-274 (1988).
71. H. Rosen, J. R. Crowley, J. W. Heinecke: Human neutrophils use the myeloperoxidase-hydrogen peroxidechloride system to chlorinate but not nitrate bacterial proteins during phagocytosis. J Biol Chem 277, 30463-30468 (2002). (Pubitemid 34970737)
72. J. Everse: The structure of heme proteins compounds I and II: some misconceptions. Free Radic Biol Med 24, 1338-1346 (1998). (Pubitemid 28253325)
73. H. Cai: Hydrogen peroxide regulation of endothelial function: Origin, mechanism and consequences. Cardiovasc Res 68, 26-36 (2005). (Pubitemid 41253553)
74. F. L. Ricciardolo, A. Di Stefano, F. Sabatini, G. Folkerts. Reactive nitrogen species in the respiratory tract. Eur J Pharmacol 533, 240-252 (2006). (Pubitemid 43340016)
75. F. L. Ricciardolo, G. Caramori, K. Ito, A. Capelli, P. Brun, G. Abatangelo, A. Papi, K. F. Chung, I. Adcock, P. J. Barnes, C. F. Donner, A. Rossi, A. Di Stefano. Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. J Allergy Clin Immunol 116, 1028-1035 (2005). (Pubitemid 41571783)
76. E. L. Thomas, M. M. Jefferson, M. B. Grisham: Myeloperoxidase-catalyzed incorporation of amines into proteins: role of hypochlorous acid and dichloramines. Biochemistry 21, 6299-6308 (1982). (Pubitemid 13141634)
77. C. C. Winterbourn, J. J. van den Berg, E. Roitman, F. A. Kuypers: Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. Arch Biochem Biophys 296, 547-555 (1992).
78. C. Bergt, S. Pennathur, X. Fu, J. Byun, K. O'Brien, T. O. McDonald, P. Singh, G. M. Anantharamaiah, A. Chait, J. Brunzell, R. L. Geary, J. F. Oram, J. W. Heinecke: The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. PNAS USA 101, 13032-13037 (2004). (Pubitemid 39167578)
79. S. Pennathur, C. Bergt, B. Shao, J. Byun, S. Y. Kassim, P. Singh, P. S. Green, T. O. McDonald, J. Brunzell, A. Chait, J. F. Oram, K. O'Brien, R. L. Geary, J. W. Heinecke: Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged y reactive nitrogen species. J Biol Chem 279, 42977-42983 (2004). (Pubitemid 39372190)
80. T. S. McMillen, J. W. Heinecke, R. C. LeBoeuf: Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice. Circulation 111, 2798-2804 (2005). (Pubitemid 40791552)
81. R. Zhang, M. L. Brennan, X. Fu, R. J. Aviles, G. L. Pearce, M. S. Penn, E. J. Topol, D. L. Sprecher, S. L. Hazen: Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286, 2136-2142 (2001). (Pubitemid 34041599)
82. M. L. Brennan, M. S. Penn, F. Van Lente, V. Nambi, M. H. Shishehbor, R. J. Aviles, M. Gormastic, M. L: Pepoy, E. S. McErlan, E. J. Topol, S. E. Nissen, S. L. Hazen: Prognostic value of myeloperoxidase in patients with chest pain. N. Engl J Med 349, 1595-1604 (2003). (Pubitemid 37288567)
83. J. A. Vita, M. L. Brennan, N. Goke, S. A. Mann, M. Goormastic, M. H. Shishehbor, M. S. Penn, J. F. Keaney Jr, S. L. Hazen: Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 110, 1134-1139 (2004). (Pubitemid 39319014)
84. F. J. Giordano: Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115, 500-508 (2005). (Pubitemid 40322219)
85. J. P. Eu, J. M. Hare, D. T. Hess, M. Skaf, J. Sun, I. Cardenas-Navina, Q. A. Sun, M. Dewhirst, G. Meissner, J. S. Stamler: Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide. PNAS USA 100, 15229-15234 (2003). (Pubitemid 37518044)
86. T. J. Mocatta, A. P. Pilbrow, V. A. Cameron, R. Senthilmohan, C. M. Frampton, A. Mark Richards, C. C. Winterbourn: Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 49, 1993-2000 (2007). (Pubitemid 46734639)
87. S. Baldus, V. Rudolph, M. Roiss, W. D. Ito, T. K. Rudholph, J. P. Eiserich, K. Sydow, D. Lau, K. Szocs, A. Klinke, L. Kubala, L. Berglund, S. Schrepfer, T. Deuse, M. Haddad, T. Risius, H. Klemm, H. C. Reichenspurner, T. Meinertz, T. Heitzer: Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 113, 1871-1878 (2006). (Pubitemid 43739399)
88. P. Salavej, H. Spalteholz, J. Arnhold: Modification of amino acid residues in human serum albumin by myeloperoxidase. Free Rad Biol Med 40, 516-525 (2006). (Pubitemid 43139687)
89. I. Mohiuddin, H. Chai, P. H. Lin, A. B. Lumsden, Q. Yao, C. Chen: Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system. J Surg Res 133, 143-149 (2006). (Pubitemid 43765765)
90. L. J. Hazell, L. Arnold, D. Flowers, G. Waeg, E. Malle, R. Stocker: Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 97, 1535-1544 (1996). (Pubitemid 26097044)
91. S. L. Hazen, J. W. Heinecke: 3-Chlotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 99, 2075-2081 (1997). (Pubitemid 27203762)
92. D. Lau, S. Baldus: Myeloperosidase and its contributory role in inflammatory vascular disease. Pharmacol Ther 111, 16-26 (2006). (Pubitemid 43765542)
93. J. Xu, Z. Xie, R. Reece, D. Pimental, M.-H. Zou: Uncoupling of endothelial nitric oxide synthase by hypochlorous acid. Role of NAD(P)H oxidase-derived superoxide and peroxynitrite. Arterioscler. Thromb. Vasc. Biol 26, 2688-2695 (2006).